The world continues to spin as we await a decision in the TC Holdings mandamus venue action.
- A group of Senators have introduced the VENUE Act (Venue Equity and Non-Uniformity Elimination Act of 2016). (S.2733). The Bill would basically limit the venues where patent infringement claims can be brought. EFF says: Pass the Venue Act
- In Acorda Therapeutics v. Mylan Pharma (Fed. Cir. 2016), the Federal Circuit found that, by filing an ANDA with the FDA, a Generic manfacturer opens itself to nationwide personal jurisdiction for patent infringement. [Patently-O Discussion]
- Sitting by designation in a district court case, Federal Circuit Judge Bryson has rejected a defendant’s contention that VE Holdings had been overruled by the 2011 amendments to the patent venue statute. Script Security Solutions, L.L.C. v. Amazon.com, LLC, No. 2:15-CV-1030-WCB, 2016 WL 1055827, (E.D. Tex. Mar. 17, 2016) (Thanks to Robert Matthews for this update).